BerganKDV Wealth Management LLC purchased a new stake in Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 790 shares of the company’s stock, valued at approximately $47,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Timber Creek Capital Management LLC increased its position in shares of Colgate-Palmolive by 247.1% in the fourth quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after acquiring an additional 336 shares during the last quarter. Farmers & Merchants Trust Co of Chambersburg PA increased its position in shares of Colgate-Palmolive by 46.2% in the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 950 shares of the company’s stock valued at $57,000 after acquiring an additional 300 shares during the last quarter. Moody National Bank Trust Division acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $94,000. Price Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $121,000. Finally, IMS Capital Management increased its position in shares of Colgate-Palmolive by 631.6% in the third quarter. IMS Capital Management now owns 2,085 shares of the company’s stock valued at $140,000 after acquiring an additional 1,800 shares during the last quarter. 74.62% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director John T. Cahill sold 5,780 shares of Colgate-Palmolive stock in a transaction dated Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the completion of the transaction, the director now owns 27,820 shares in the company, valued at $1,793,277.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive stock opened at $65.69 on Friday. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $72.61. The stock has a market cap of $56.97 billion, a P/E ratio of 22.12, a price-to-earnings-growth ratio of 4.24 and a beta of 0.78.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.78 billion. During the same quarter last year, the company posted $0.75 earnings per share. Colgate-Palmolive’s quarterly revenue was down 2.1% on a year-over-year basis. On average, analysts forecast that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Wednesday, January 23rd will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.56%. The ex-dividend date is Tuesday, January 22nd. Colgate-Palmolive’s payout ratio is currently 56.57%.
A number of analysts recently issued reports on CL shares. Goldman Sachs Group raised Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 30th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $61.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 1st. Morgan Stanley lowered their target price on Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research report on Tuesday, October 30th. Finally, JPMorgan Chase & Co. downgraded Colgate-Palmolive from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $61.00 to $54.00 in a research report on Monday, October 29th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $65.00.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
See Also: Understanding Analyst Ratings